Anu Haveri

756 total citations
19 papers, 230 citations indexed

About

Anu Haveri is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Anu Haveri has authored 19 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Anu Haveri's work include SARS-CoV-2 and COVID-19 Research (8 papers), Reproductive tract infections research (6 papers) and Influenza Virus Research Studies (5 papers). Anu Haveri is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Reproductive tract infections research (6 papers) and Influenza Virus Research Studies (5 papers). Anu Haveri collaborates with scholars based in Finland, Sweden and United States. Anu Haveri's co-authors include Hanna Nohynek, Niina Ikonen, Riitta Lahesmaa, Mirja Puolakkainen, Nina Ekström, Merit Melin, Pamela Österlund, Arto A. Palmu, Camilla Virta and Jenni M. Vuola and has published in prestigious journals such as Scientific Reports, The Journal of Infectious Diseases and Infection and Immunity.

In The Last Decade

Anu Haveri

19 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anu Haveri Finland 9 119 77 56 39 29 19 230
Kina Helm Netherlands 9 78 0.7× 154 2.0× 43 0.8× 160 4.1× 27 0.9× 10 269
Л. В. Колобухина Russia 7 96 0.8× 72 0.9× 12 0.2× 19 0.5× 16 0.6× 26 184
María Ubals Spain 8 180 1.5× 73 0.9× 17 0.3× 47 1.2× 26 0.9× 14 335
Hye Hee South Korea 12 226 1.9× 56 0.7× 23 0.4× 10 0.3× 17 0.6× 19 270
Helen R. Wagstaffe United Kingdom 9 124 1.0× 39 0.5× 88 1.6× 7 0.2× 22 0.8× 13 213
Nina Ekström Finland 13 126 1.1× 280 3.6× 132 2.4× 138 3.5× 43 1.5× 24 507
Donchida Srimuan Thailand 11 296 2.5× 71 0.9× 50 0.9× 41 1.1× 26 0.9× 27 362
Audrey L. Butler United States 6 165 1.4× 60 0.8× 116 2.1× 9 0.2× 35 1.2× 7 343
Johan Ringlander Sweden 12 128 1.1× 106 1.4× 40 0.7× 131 3.4× 73 2.5× 33 380
Céline Boschi France 11 170 1.4× 99 1.3× 18 0.3× 7 0.2× 70 2.4× 29 279

Countries citing papers authored by Anu Haveri

Since Specialization
Citations

This map shows the geographic impact of Anu Haveri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anu Haveri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anu Haveri more than expected).

Fields of papers citing papers by Anu Haveri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anu Haveri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anu Haveri. The network helps show where Anu Haveri may publish in the future.

Co-authorship network of co-authors of Anu Haveri

This figure shows the co-authorship network connecting the top 25 collaborators of Anu Haveri. A scholar is included among the top collaborators of Anu Haveri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anu Haveri. Anu Haveri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ekström, Nina, Toni Lehtonen, Anu Haveri, et al.. (2024). Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19. Vaccines. 12(3). 247–247. 5 indexed citations
2.
Krzyżewska, Eva, Anu Haveri, C Hammer, et al.. (2022). Impaired immunity and high attack rates caused by SARS‐CoV‐2 variants among vaccinated long‐term care facility residents. Immunity Inflammation and Disease. 10(9). e679–e679. 3 indexed citations
3.
Dub, Timothée, Merit Melin, Anu Haveri, et al.. (2021). COVID-19 outbreak at a reception centre for asylum seekers in Espoo, Finland. Journal of Migration and Health. 3. 100043–100043. 6 indexed citations
4.
Koskinen, Juha, Kristina Hotakainen, Anu Haveri, et al.. (2021). Clinical validation of automated and rapid mariPOC SARS-CoV-2 antigen test. Scientific Reports. 11(1). 20363–20363. 8 indexed citations
5.
Haveri, Anu, Nina Ekström, Camilla Virta, et al.. (2021). Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans. European Journal of Immunology. 51(12). 3202–3213. 60 indexed citations
6.
Haveri, Anu, Niina Ikonen, Carita Savolainen‐Kopra, & Ilkka Julkunen. (2020). Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines. Vaccine. 39(2). 402–411. 5 indexed citations
7.
Nohynek, Hanna, Ritva Syrjänen, Jukka Ollgren, et al.. (2020). Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients – a prospective observational study. Infectious Diseases. 53(2). 111–121. 31 indexed citations
8.
Haveri, Anu, Niina Ikonen, Anu Kantele, et al.. (2019). Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses. Vaccine. 37(20). 2731–2740. 2 indexed citations
9.
Baum, Ulrike, Mia Brytting, Niina Ikonen, et al.. (2017). Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 3 indexed citations
10.
Seppälä, Elina, Janko van Beek, Anu Haveri, et al.. (2017). A cluster of measles linked to an imported case, Finland, 2017. Eurosurveillance. 22(33). 4 indexed citations
11.
12.
Haveri, Anu, Niina Ikonen, Ilkka Julkunen, et al.. (2015). Reduced cross-protection against influenza A(H3N2) subgroup 3C.2a and 3C.3a viruses among Finnish healthcare workers vaccinated with 2013/14 seasonal influenza vaccine. Eurosurveillance. 20(5). 21028–21028. 13 indexed citations
13.
Ikonen, Niina, et al.. (2013). Influenssakausi Suomessa, viikot 40/2012-20/2013 - Seurantaraportti. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 4 indexed citations
14.
Puolakkainen, Mirja, et al.. (2012). Flotillin-1 (Reggie-2) Contributes to Chlamydia pneumoniae Growth and Is Associated with Bacterial Inclusion. Infection and Immunity. 80(3). 1072–1078. 14 indexed citations
15.
Puolakkainen, Mirja, et al.. (2011). Chlamydia pneumoniae entry into epithelial cells by clathrin-independent endocytosis. Microbial Pathogenesis. 52(3). 157–164. 18 indexed citations
16.
Haveri, Anu, et al.. (2009). Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection. Microbial Pathogenesis. 46(5). 235–242. 6 indexed citations
17.
Haveri, Anu, et al.. (2008). Chlamydia pneumoniae infection in IL-10 knock out mice: Accelerated clearance but severe pulmonary inflammatory response. Microbial Pathogenesis. 45(1). 25–29. 19 indexed citations
18.
Mannonen, Laura, Anu Haveri, Arja Reinikainen, et al.. (2006). Up‐Regulation of Host Cell Genes during Interferon‐γ–Induced PersistentChlamydia pneumoniaeInfection in HL Cells. The Journal of Infectious Diseases. 195(2). 212–219. 8 indexed citations
19.
Haveri, Anu, Steve Pascolo, Riitta Lahesmaa, et al.. (2005). Clearance of Chlamydia pneumoniae Infection in H‐2 Class I–/– Human Leucocyte Antigen‐A2.1 Monochain Transgenic Mice. Scandinavian Journal of Immunology. 62(2). 131–139. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kina Helm Breakdown of academic impact, for papers by Л. В. Колобухина Breakdown of academic impact, for papers by María Ubals Breakdown of academic impact, for papers by Hye Hee Breakdown of academic impact, for papers by Helen R. Wagstaffe Breakdown of academic impact, for papers by Nina Ekström Breakdown of academic impact, for papers by Donchida Srimuan Breakdown of academic impact, for papers by Audrey L. Butler Breakdown of academic impact, for papers by Johan Ringlander Breakdown of academic impact, for papers by Céline Boschi
Rankless by CCL
2026